Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps

Trending Investment Opportunities

The FDA has announced that Medtronic Plc MDT has expanded the Class I recall of its MiniMed 600 series insulin pumps.
Medtronic is offering to replace all MiniMed 600 series insulin pumps that have a clear retainer ring. The retainer ring helps to lock the insulin cartridge into place in the pump's reservoir compartment.
If the cartridge is not locked firmly into place, under or over insulin delivery may occur.
In a separate update, FDA said Medtronic expanded an August 2018 recall of remote controllers used with the MiniMed 508 and Paradigm family of insulin pumps due to cybersecurity risks.
FDA said it was unaware of any reports of harm to patients related to the cybersecurity problem.
The FDA said that Medtronic is recalling 31,310 devices because an unauthorized person could record the wireless communication between the remote and insulin pump.
Patients who have not programmed a remote controller ID into the pump or selected the related bolus option are not affected.
Related: Medtronic Pulls Plug On Heart Implant Device Amid Growing Concerns Over Patient Safety.
Price Action: MDT stock is down 0.20% at $125.55 during the market session on the last check Wednesday.

Momentum56.59

Growth57.27

Quality38.34

Value24.80

Short

Medium

Long